C.Difficile Diarrhea clinical trials at University of California Health

1 research study open to eligible people

VE303 for Prevention of Recurrent Clostridioides Difficile Infection
open to eligible people ages 12 years and up
The overall objective of the RESTORATiVE303 study is to evaluate the safety and the Clostridioides difficile infection (CDI) recurrence rate at Week 8 in participants who receive a 14-day course of VE303 or matching placebo. The objectives and…
at UCLA UCSD

Last updated: March 17, 2025